NasdaqCM - Delayed Quote • USD Sunshine Biopharma, Inc. (SBFMW) Follow 0.0800 0.0000 (0.00%) At close: May 30 at 4:00 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54% NEW YORK, NY / ACCESSWIRE / May 21, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced ... 3 Meme Stocks to Sell That Even Roaring Kitty Can’t Save This week will go down in market history as the return of Roaring Kitty. Keith Gill — known as Roaring Kitty on social media — the Massachusetts man credited with launching the GameStop (NYSE:GME) short squeeze of 2021, picked an interesting time to return to social media. After a long hiatus, he shared an apparently hand-drawn photo on X of a man playing video games, launching a meme stock frenzy. Unsurprisingly, both GameStop and AMC Entertainment (NYSE:AMC) quickly surged. After a solid two-d Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) NEW YORK, NY / ACCESSWIRE / April 19, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that ... Sunshine Biopharma Announces Reverse Stock Split NEW YORK, NY / ACCESSWIRE / April 12, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company" or "Sunshine Biopharma"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology ... Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023 Sales Grew at an Average Rate of 14% Per Quarter During the Year NEW YORK, NY / ACCESSWIRE / April 1, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety ... Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags Sunshine Biopharma ( NASDAQ:SBFM ) Full Year 2023 Results Key Financial Results Revenue: US$24.1m (up 454% from FY... Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering NEW YORK, NY / ACCESSWIRE / February 15, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today ... Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering NEW YORK, NY / ACCESSWIRE / February 13, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today ... 11 Hyper-Growth Stocks Billionaires Are Loading Up On In this article, we will take a detailed look at the 11 Hyper-Growth Stocks Billionaires Are Loading Up On. For a quick overview of such stocks, read our article 5 Hyper-Growth Stocks Billionaires Are Loading Up On. Growth stocks have rewarded investors over the past several years, thanks to the hyper growth and mind-numbing expansion of technology companies […] Analysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM) Sunshine Biopharma, Inc. ( NASDAQ:SBFM ) is possibly approaching a major achievement in its business, so we would like... Sunshine Biopharma Moves Principal Office to New York City NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM”) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has moved its headquarters to New York City. The Company’s Head Office is now located at 1177 Avenue of the Americas, 5th Floor, New York, NY 10036 (Tel: 332-216-1147). The Company will maintain a satellite office at its previous hea Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition MONTREAL, QC / ACCESSWIRE / November 13, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today ... Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has received a 180-day extension, until March 18, 2024, to achieve compliance with the Nasdaq $1.00 minimum bid price rule. It's Down 26% But Sunshine Biopharma, Inc. (NASDAQ:SBFM) Could Be Riskier Than It Looks To the annoyance of some shareholders, Sunshine Biopharma, Inc. ( NASDAQ:SBFM ) shares are down a considerable 26% in... When Will Sunshine Biopharma, Inc. (NASDAQ:SBFM) Breakeven? With the business potentially at an important milestone, we thought we'd take a closer look at Sunshine Biopharma... Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600% MONTREAL, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”) (the “Company”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its quarterly report for the 2023 second quarter. The Company reported gross revenues of $5,560,865 for the quarter ended June 30, 2023, an increase of 3,600% over the same period in 2022. The increase was largely due to the
